RUCAVEN

Rucaven (Rucaparib) is a novel drug used for the treatment of ovarian cancer. It is a type of PARP inhibitor, which works by blocking the activity of an enzyme called poly (ADP-ribose) polymerase (PARP), which helps repair damaged DNA in cells. By blocking PARP, Rucaparib can help prevent cancer cells from repairing their DNA, which can lead to their death.